Dormant hypermethylated tumour suppressor genes: questions and answers
- 10 January 2005
- journal article
- review article
- Published by Wiley in The Journal of Pathology
- Vol. 205 (2) , 172-180
- https://doi.org/10.1002/path.1707
Abstract
The epigenetic inactivation of tumour suppressor genes by promoter CpG island methylation is nowadays one of the hottest topics in cancer research. However, there are still several important open questions: Can we use CpG island hypermethylation to classify tumours according to their clinical behaviour and chemosensitivity? How do we prove that our hypermethylated gene is important for cancer development and/or progression? Which enzymes are directly responsible for the CpG island hypermethylation of tumour suppressor genes? How is the chromatin structure and molecular environment in and around the hypermethylated CpG islands? Can we wake up these dormant hypermethylated tumour suppressor genes in an epigenetic therapy of cancer? Some answers are provided in this review, but other questions remain unsolved, awaiting the eager epigenetic researcher. Copyright © 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 71 references indexed in Scilit:
- CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancerOncogene, 2004
- A Mouse Skin Multistage Carcinogenesis Model Reflects the Aberrant DNA Methylation Patterns of Human TumorsCancer Research, 2004
- Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignanciesBlood, 2004
- Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferasesHuman Molecular Genetics, 2003
- The Methyl-CpG-binding Protein MeCP2 Links DNA Methylation to Histone MethylationJournal of Biological Chemistry, 2003
- Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumorsNature Genetics, 2003
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cellsNature, 2002
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000
- Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinomaProceedings of the National Academy of Sciences, 1998
- Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNACell, 1992